Announcement of TTY Biopharm's unaudited income information in May 2020
2020.6.11
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2020/06/11 | Time of announcement | 14:48:09 |
| Subject | Announcement of TTY Biopharm's unaudited income information in May 2020 | ||||
| Date of events | 2020/06/11 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2020/06/11 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $267,055 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $49,307 thousands, and a consolidated income before tax of $69,731 thousands in May 2020; net income attributed to stockholders of the company was $60,990 thousands; EPS is $0.25. Year-to-date consolidated net sales was $1,716,528 thousands (in NT dollars; unaudited), a consolidated operating profit was $432,201 thousands and consolidated income before tax was $492,435 thousands until May 2020; year-to-date net income attributed to stockholders of the company was $391,733 thousands; EPS is $1.58. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||